Company Filing History:
2 out of 138 
2 out of 109 
2 out of 1,455 
Years Active: 2018-2024
Title: The Innovations of Dominique Louis Leon Swinnen
Introduction
Dominique Louis Leon Swinnen is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of four patents to his name, Swinnen's work focuses on developing compounds that can address various human ailments.
Latest Patents
Swinnen's latest patents include a series of fused pentacyclic imidazole derivatives. These compounds are recognized as potent modulators of human TNFa activity. They hold promise in the treatment and prevention of a wide range of human ailments, including autoimmune and inflammatory disorders, neurological and neurodegenerative disorders, pain and nociceptive disorders, cardiovascular disorders, metabolic disorders, ocular disorders, and oncological disorders. Specifically, his inventions concern 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and their analogs.
Career Highlights
Throughout his career, Swinnen has worked with prominent companies in the biopharmaceutical sector, including UCB Biopharma Sprl and UCB Biopharma Srl. His expertise in the field has allowed him to contribute to significant advancements in drug development.
Collaborations
Swinnen has collaborated with various professionals in his field, including Mark Daniel Calmiano and Michael Deligny. These collaborations have further enhanced his research and development efforts.
Conclusion
Dominique Louis Leon Swinnen is a distinguished inventor whose work has the potential to impact the treatment of numerous health conditions. His innovative patents reflect his commitment to advancing medical science and improving patient outcomes.